TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 51 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $28,000 | -30.0% | 58,972 | +2.8% | 0.00% | – |
Q3 2016 | $40,000 | -54.5% | 57,350 | +29.9% | 0.00% | – |
Q2 2016 | $88,000 | -18.5% | 44,140 | -1.7% | 0.00% | – |
Q1 2016 | $108,000 | -70.9% | 44,904 | -7.2% | 0.00% | – |
Q4 2015 | $371,000 | +51.4% | 48,368 | +4.6% | 0.00% | – |
Q3 2015 | $245,000 | -35.2% | 46,263 | +9.7% | 0.00% | – |
Q2 2015 | $378,000 | +34.0% | 42,167 | -5.5% | 0.00% | – |
Q1 2015 | $282,000 | +67.9% | 44,598 | +54.7% | 0.00% | – |
Q4 2014 | $168,000 | -8.2% | 28,825 | +7.7% | 0.00% | – |
Q3 2014 | $183,000 | -51.1% | 26,773 | +2.7% | 0.00% | – |
Q2 2014 | $374,000 | – | 26,070 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 392,952 | $4,051,000 | 0.53% |
BLUESTEIN R H & CO LLC | 179,800 | $1,854,000 | 0.12% |
Edge Wealth Management LLC | 15,000 | $154,000 | 0.07% |
Tower Research Capital LLC (TRC) | 1,316 | $14,000 | 0.00% |
VANGUARD GROUP INC | 37,190 | $384,000 | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 100 | $1,000 | 0.00% |
UBS AG | 1,878 | $19,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 106 | $1,000 | 0.00% |
FIRST MANHATTAN CO. LLC. | 2,500 | $25,000 | 0.00% |
CREDIT SUISSE AG/ | 19,370 | $200,000 | 0.00% |